HPV genotypes in invasive cervical cancer: prevalence, risk attribution, and optimized vaccine strategies in western China
Our comprehensive postsurgical analysis of HPV in ICC patients in western China revealed that the incorporation of the bivalent vaccine into the national program is cost-effective, with group A optimization closely matching the vaccination coverage of the 9-valent vaccine, which can be used to guide future prevention strategies.
Authors
- Qingfeng He (ORCID: https://orcid.org/0000-0001-5795-1550)
- Dongni Liang
- Chuan Xie (ORCID: https://orcid.org/0000-0001-5748-3443)
- Jing Zeng (ORCID: https://orcid.org/0000-0001-8953-9042)
- Meng Chen (ORCID: https://orcid.org/0000-0003-0774-3133)
- Mei Wang (ORCID: https://orcid.org/0000-0003-4483-7286)
- Zhonghua Li (ORCID: https://orcid.org/0000-0002-7625-7043)
- Tianming Liu (ORCID: https://orcid.org/0000-0003-2245-7231)
- Cheng Wang (ORCID: https://orcid.org/0000-0001-6075-2878)
- Wenjing Fu
- Xiao Tang (ORCID: https://orcid.org/0000-0003-2884-3790)
- Yanqi Kou (ORCID: https://orcid.org/0000-0001-8456-7474)
- Wei J. Wang (ORCID: https://orcid.org/0000-0002-4848-7394)
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2024-12-18
- DOI
- https://doi.org/10.3389/fpubh.2024.1455931
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39